PCDx test performs better than FoundationOne test in clinical study

[News]

Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.

More... (http://www.news-medical.net/news/20150428/PCDx-test-performs-better-than-FoundationOne-test-in-clinical-study.aspx)